W. L. Gore & Associates (Gore) announced the release of three-year data from the Gore ASSURED Clinical Study (ASSURED Study) in the September 2024 online issue of JACC: Cardiovascular Interventions, evaluating the long-term safety and efficacy of treating ostium secundum ASDs with the GORE® CARDIOFORM ASD Occluder.
The ASSURED Study data demonstrated long-term safety and efficacy of the GORE CARDIOFORM ASD Occluder at 6, 12 and 36 months, with 100 percent closure success* rate among patients evaluated at 36 months (n = 357).
Ähnliche Beiträge
KI kann die Rente retten
Künstliche Intelligenz (KI) bietet Chancen, das deutsche Rentensystem trotz alternder Bevölkerung und sinkender Beitragszahler zu stabilisieren. Durch effizientere Verwaltung, bessere Prüfung von Sozialbeiträgen und die…
Trump Offloads Ebola-Infected American Citizen to Germany
Berlin/Washington (LabNews Media LLC) – A U.S. medical missionary infected with the Bundibugyo strain of Ebola virus disease (EVD) has been evacuated to Berlin’s Charité…
Kanada investiert 6,8 Millionen Dollar in KI-Projekte in Alberta
Edmonton (LabNews Media LLC) – Die kanadische Bundesregierung fördert fünf Projekte in Alberta mit insgesamt 6,8 Millionen Dollar über die Regional Artificial Intelligence Initiative (RAII).…
